Lincoln Pharmaceuticals Ltd
NSE:LINCOLN

Watchlist Manager
Lincoln Pharmaceuticals Ltd Logo
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Watchlist
Price: 554.75 INR 2.74% Market Closed
Market Cap: 11.1B INR

Intrinsic Value

The intrinsic value of one LINCOLN stock under the Base Case scenario is 795.89 INR. Compared to the current market price of 554.75 INR, Lincoln Pharmaceuticals Ltd is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LINCOLN Intrinsic Value
795.89 INR
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Lincoln Pharmaceuticals Ltd

LINCOLN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for LINCOLN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
IN
Pharmaceuticals
Market Cap
11.1B INR
IPO
Feb 8, 1996
IN
Pharmaceuticals
Market Cap
11.1B INR
IPO
Feb 8, 1996
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LINCOLN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Lincoln Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lincoln Pharmaceuticals Ltd

Current Assets 5.2B
Cash & Short-Term Investments 2B
Receivables 2.2B
Other Current Assets 980.9m
Non-Current Assets 2.6B
Long-Term Investments 5.2m
PP&E 1.8B
Intangibles 3.2m
Other Non-Current Assets 724.4m
Efficiency

Free Cash Flow Analysis
Lincoln Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lincoln Pharmaceuticals Ltd

Revenue
6B INR
Cost of Revenue
-2.8B INR
Gross Profit
3.1B INR
Operating Expenses
-2.3B INR
Operating Income
808m INR
Other Expenses
85.7m INR
Net Income
893.7m INR
Fundamental Scores

LINCOLN Profitability Score
Profitability Due Diligence

Lincoln Pharmaceuticals Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Revenue Growth Forecast
59/100
Profitability
Score

Lincoln Pharmaceuticals Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

LINCOLN Solvency Score
Solvency Due Diligence

Lincoln Pharmaceuticals Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Lincoln Pharmaceuticals Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LINCOLN Price Targets Summary
Lincoln Pharmaceuticals Ltd

Wall Street analysts forecast LINCOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LINCOLN is 1 028.16 INR with a low forecast of 1 018.08 INR and a high forecast of 1 058.4 INR.

Lowest
Price Target
1 018.08 INR
84% Upside
Average
Price Target
1 028.16 INR
85% Upside
Highest
Price Target
1 058.4 INR
91% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LINCOLN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LINCOLN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LINCOLN stock?

The intrinsic value of one LINCOLN stock under the Base Case scenario is 795.89 INR.

Is LINCOLN stock undervalued or overvalued?

Compared to the current market price of 554.75 INR, Lincoln Pharmaceuticals Ltd is Undervalued by 30%.

Back to Top